NewsBenzingaHC Wainwright & Co.维持对ArriVent BioPharma的“买入”评级，将目标价下调至27美元 HC Wainwright & Co.维持对ArriVent BioPharma的“买入”评级，将目标价下调至27美元 Benzinga 2026.10.08 10:32 (GMT+0) Open on Benzinga Other news Wells Fargo Maintains Equal-Weight on Sonoco Products, Lowers Price Target to $53 Piper Sandler Maintains Neutral on WaFd, Lowers Price Target to $31 VinFast Says Real Estate Could Cover Its EV Cash Burn Wells Fargo Maintains Overweight on Silgan Hldgs, Lowers Price Target to $52 Piper Sandler Maintains Neutral on First Finl Bankshares, Lowers Price Target to $33 $1000 Invested In Extra Space Storage 20 Years Ago Would Be Worth This Much Today
